Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma

Volume: 21, Issue: 1
Published: Sep 8, 2021
Abstract
Background Xanthine dehydrogenase (XDH) is a critical enzyme involved in the oxidative metabolism of purines, pterin and aldehydes and a central component of the innate immune system. However, the prognostic value of XDH in predicting tumor-infiltrating lymphocyte abundance, the immune response, and survival in different cancers, including hepatocellular carcinoma (HCC), is still unclear. Methods XDH expression was analyzed in multiple...
Paper Details
Title
Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma
Published Date
Sep 8, 2021
Volume
21
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.